Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The system-level paracrine milieu refers to the collective environment of locally acting signaling molecules, including cytokines, chemokines, growth factors, and extracellular vesicles, that mediate communication between adjacent cells within a tissue or organ system (Gnecchi et al., 2016). This milieu is essential for maintaining tissue homeostasis and coordinating responses to injury, but its dysregulation is a central feature of many diseases, such as the pro-inflammatory environment in chronic inflammatory conditions and the immunosuppressive niche in the tumor microenvironment (Whiteside, 2008). In the context of regenerative medicine, the therapeutic benefits of cell-based therapies, particularly those involving mesenchymal stem cells, are often attributed to the secretome or the ability of these cells to alter the paracrine milieu to favor repair and immunomodulation (Caplan & Correa, 2011). Because the paracrine milieu represents a complex network of diverse molecular entities rather than a single protein or receptor, it is not classified as a specific therapeutic target in the traditional sense. Instead, drug development typically focuses on individual components within this milieu, such as specific interleukins or growth factor receptors, to achieve precise therapeutic effects (Karin et al., 2006). Monitoring the composition of this milieu through secretome analysis or cytokine profiling can provide valuable biomarkers for disease progression and treatment efficacy (Teixeira et al., 2013). Therapeutic strategies aiming to modulate the entire milieu, such as stem cell transplantation, face challenges regarding the standardization of the secreted factors and potential off-target effects (Galipeau & Sensébé, 2018).
Not applicable as this is a collective signaling environment rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on System-level paracrine milieu.